Cite

HARVARD Citation

    Liu, M. et al. (2020). Targeting monocyte-intrinsic enhancer reprogramming improves immunotherapy efficacy in hepatocellular carcinoma. Gut. 69 (2), pp. 365-379. [Online]. 
  
Back to record